Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion type Assertion NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_head.
- NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion description "[Comprehensive genomic profiling of relapsed CDH1-mutated ILC revealed actionable genomic alterations in 86% of cases, featured a high incidence of ERBB2 alterations, and can reveal actionable alterations that can inform treatment decisions for patients with ILC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_provenance.
- NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion evidence source_evidence_literature NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_provenance.
- NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion SIO_000772 23575477 NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_provenance.
- NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion wasDerivedFrom befree-20140225 NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_provenance.
- NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_assertion wasGeneratedBy ECO_0000203 NP593787.RAPgFTBycSCEDskeHMaJTkMIhfrX4Z6QQ0n7ZiZfMuH_s130_provenance.